December 13, 2016

Press release - Non-regulatory

Targovax to present at DNB healthcare conference

December 9, 2016

Press release - Regulatory

Targovax ASA: Grant of share options

November 21, 2016

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of employee options

November 21, 2016

Press release - Regulatory

Targovax ASA: Exercise of employee share options in Targovax ASA

November 18, 2016

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider

November 17, 2016

Press release - Regulatory

Targovax ASA: Third quarter 2016 results

November 16, 2016

Press release - Non-regulatory

Targovax to present at forthcoming conference

November 10, 2016

Press release - Regulatory

Targovax granted European Patent for ONCOS platform lead product, ONCOS-102

November 8, 2016

Press release - Regulatory

Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November

November 4, 2016

Press release - Regulatory

Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

November 2, 2016

Press release - Non-regulatory

Targovax ASA: GRANT OF SHARE OPTIONS

November 2, 2016

Press release - Non-regulatory

Targovax ASA: GRANT OF SHARE OPTIONS

November 2, 2016

Press release - Non-regulatory

Targovax announces appointment of Oystein Soug as CEO

October 21, 2016

Press release - Non-regulatory

Targovax presents ONCOS-102 scientific rationale at the European Society of Gene and Cell Therapy

October 17, 2016

Press release - Non-regulatory

Targovax to Present at the ESGCT/ISSCR Stem Cells & Gene Therapy Symposium

September 19, 2016

Press release - Non-regulatory

Targovax to present at Redeye’s Fight Cancer conference

September 14, 2016

Press release - Non-regulatory

Targovax to present at forthcoming conferences

August 25, 2016

Press release - Regulatory

Targovax ASA: Interim Report second quarter and first half year 2016

August 17, 2016

Press release - Non-regulatory

Targovax ASA: Completion of subsequent offering, registration of share capital increase

August 17, 2016

Press release - Non-regulatory

Targovax ASA: Completion of subsequent offering, registration of share capital increase

August 15, 2016

Press release - Regulatory

Targovax ASA: Invitation to second quarter 2016 results presentation Thursday 25 August

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Allocations to primary insiders in the subsequent offering

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Result of the subsequent offering

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Allocations to primary insiders in the subsequent offering

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Result of the subsequent offering

August 8, 2016

Press release - Non-regulatory

Targovax ASA – Last day of the subscription period in the subsequent offering

August 8, 2016

Press release - Non-regulatory

Targovax ASA – Last day of the subscription period in the subsequent offering

August 4, 2016

Press release - Non-regulatory

Anne-Sophie Møller joins Targovax

August 4, 2016

Press release - Non-regulatory

Anne-Sophie Møller joins Targovax

August 4, 2016

Press release - Non-regulatory

Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET

August 4, 2016

Press release - Non-regulatory

Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET

July 11, 2016

Press release - Non-regulatory

Targovax ASA: Commencement of subscription period for the subsequent offering

July 8, 2016

Press release - Non-regulatory

Targovax ASA: Publication of prospectus, listing on Oslo Axess and subsequent offering

July 7, 2016

Press release - Non-regulatory

Targovax ASA: Completion of private placement, registration of share capital increase

July 6, 2016

Press release - Non-regulatory

Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

July 6, 2016

Press release - Regulatory

Targovax presents encouraging preclinical data on ONCOS-102

July 1, 2016

Press release - Non-regulatory

Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma

July 1, 2016

Press release - Regulatory

Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma

June 22, 2016

Press release - Non-regulatory

Notice of Extraordinary General Meeting

June 22, 2016

Press release - Non-regulatory

Targovax ASA: Announcement of successful NOK 110 million private placement

June 21, 2016

Press release - Non-regulatory

Targovax ASA: Update on bookbuilding for the private placement of NOK 100 – 130 million

June 20, 2016

Press release - Non-regulatory

Targovax ASA: Contemplated private placement of NOK 100 – 130 million

June 14, 2016

Press release - Regulatory

Targovax granted US Patent for oncolytic virus ONCOS-102

June 9, 2016

Press release - Regulatory

Targovax receives regulatory approval in Spain to conduct a clinical trial with its oncolytic virus ONCOS-102

June 7, 2016

Press release - Regulatory

Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed

June 2, 2016

Press release - Regulatory

Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations

May 31, 2016

Press release - Non-regulatory

Targovax to present at forthcoming conferences

May 20, 2016

Press release - Non-regulatory

Magnus Jaderberg, CMO of Targovax, has presented at a symposium by The Royal Swedish Academy of Engineering Sciences

May 12, 2016

Press release - Regulatory

Targovax ASA: Interim report first quarter 2016

May 9, 2016

Press release - Regulatory

Targovax to present at BioEquity Europe and its first quarter 2016 results on May 11 – 12, 2016

May 9, 2016

Press release - Non-regulatory

Targovax ASA: Registration of share capital increase following exercise of employee options

April 29, 2016

Press release - Non-regulatory

Exercise of employee share options in Targovax ASA

April 16, 2016

Press release - Non-regulatory

Annual Report 2015

April 15, 2016

Press release - Non-regulatory

Targovax ASA: Grant of restricted stock units to the Board of directors

April 14, 2016

Press release - Regulatory

Targovax reports immune response with reduced number of TG01 vaccinations

April 14, 2016

Press release - Non-regulatory

Resolution to increase the share capital in Targovax ASA in relation to exercise of employee options

March 15, 2016

Press release - Non-regulatory

Targovax to present at forthcoming Life Science and Investor conferences

March 14, 2016

Press release - Regulatory

Targovax to present at forthcoming Life Science and Investor conferences

March 14, 2016

Press release - Non-regulatory

Sachs Zürich March 2016

March 11, 2016

Press release - Non-regulatory

Targovax in Dagens Medisin

March 10, 2016

Press release - Regulatory

Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer

March 7, 2016

Press release - Non-regulatory

Targovax in BioCentury cover story

March 2, 2016

Press release - Regulatory

Targovax ASA: Interim report fourth quarter 2015

February 25, 2016

Press release - Regulatory

CORRECTION: Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

February 25, 2016

Press release - Regulatory

Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

February 2, 2016

Press release - Regulatory

Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain